Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 69
Filter
1.
Radiat Prot Dosimetry ; 167(1-3): 298-301, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25948825

ABSTRACT

The Bundesamt für Strahlenschutz (Berlin, Germany) and the Paul Scherrer Institute (Villigen, Switzerland) both operate accredited calibration laboratories for radon gas activity concentration. Both the institutions use Lucas Cells as detector in their reference instrumentation due to the low dependence of this detector type on variations in environmental conditions. As a further measure to improve the quality of the reference activity concentration, a spectrometric method of data evaluation has been applied. The electric pulses from the photomultiplier tube coupled to the Lucas Cells are subjected to a pulse height analysis. The stored pulse height spectra are analysed retrospectively to compensate for fluctuations in the electric parameters of the instrumentation during a measurement. The reference instrumentation of both the laboratories is described with the respective spectrum evaluation procedures. The methods of obtaining traceability to the primary calibration laboratories of Germany and Switzerland and data of performance tests are presented.


Subject(s)
Radon/analysis , Scintillation Counting/instrumentation , Scintillation Counting/standards , Spectrum Analysis/instrumentation , Spectrum Analysis/standards , Calibration/standards , Equipment Design , Equipment Failure Analysis , Germany , Radon/standards , Reference Values , Reproducibility of Results , Sensitivity and Specificity , Switzerland
2.
Radiat Prot Dosimetry ; 158(1): 59-67, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23878346

ABSTRACT

This paper analyses the data having been gathered from interlaboratory comparisons of passive radon instruments over 10 y with respect to the measurement accuracy. The measurement accuracy is discussed in terms of the systematic and the random measurement error. The analysis shows that the systematic measurement error of the most instruments issued by professional laboratory services can be within a range of ±10 % from the true value. A single radon measurement has an additional random measurement error, which is in the range of up to ±15 % for high exposures to radon (>2000 kBq h m(-3)). The random measurement error increases for lower exposures. The analysis especially applies to instruments with solid-state nuclear track detectors and results in proposing criteria for testing the measurement accuracy. Instruments with electrets and charcoal have also been considered, but the low stock of data enables only a qualitative discussion.


Subject(s)
Air Pollutants, Radioactive/analysis , Air Pollution, Indoor/analysis , Laboratories/standards , Radiation Monitoring/instrumentation , Radiometry/instrumentation , Radon/analysis , Humans , Radiation Dosage , Radiation Monitoring/standards , Radiation Protection
3.
Radiat Prot Dosimetry ; 125(1-4): 572-5, 2007.
Article in English | MEDLINE | ID: mdl-17562644

ABSTRACT

Since 2003, the German Federal Office for Radiation Protection (BfS) has conducted annual interlaboratory comparisons for passive radon measuring devices in order to ensure the quality of these measurements. Passive radon devices which use solid state nuclear track detectors, electrets or activated charcoal can be tested. The exposures of radon devices are carried out in the radon calibration laboratory at BfS. Radon activity concentrations are traced back to the national standard, being established at the National Institute of Physics and Metrology (PTB). According to the national guideline, radon services which offer radon monitoring at workplaces have to participate in the intercomparisons and prove the suitability of their radon devices for the measurements.


Subject(s)
Air Pollution, Indoor/analysis , Environmental Exposure/analysis , Laboratories , Radiation Monitoring/methods , Radiation Protection/methods , Radon/analysis , Germany , Humans , Internationality , Radiation Dosage , Reproducibility of Results , Sensitivity and Specificity
4.
Z Gastroenterol ; 41(12): 1151-6, 2003 Dec.
Article in German | MEDLINE | ID: mdl-14661124

ABSTRACT

BACKGROUND AND AIMS: The stomach is the main site of primary extranodular manifestation of non-Hodgkin's lymphomas. Besides clinical staging additional to histological diagnoses, the endoscopic ultrasound (EUS) also becomes more important during follow-up courses of conservative therapy regimens (e. g. H.p. eradication; radiochemotherapy). The aim of the present study was to assess the impact of EUS during long-term observation of primary gastric lymphomas and to outline possible changes of the gastric wall. PATIENTS AND METHODS: Within the scope of 2 prospective multicenter study on primary gastrointestinal non-Hodgkin's lymphomas (GIT-NHL), which were performed at Muenster University Hospital, 26 patients undergoing conservative treatment were examined with endoscopic ultrasound at a three-month interval between 01/1992 and 11/1998. The mean survey period was 28 months (range 7-62). RESULTS: In 22 patients over a period of 21 months (range 4-51) a histological proven complete remission (CR) was found. In 2 patients only a partial remission (PR) was achieved within a time period of seven respectively eight months of survey. Two other patients developed early relapse of non-Hodgkin's lymphoma. In patients with CR the endoscopic ultrasound showed a highly significant decrease of gastric wall thickness 7 and 12 months after therapy was started. On average after 4.6 months enlarged lymph nodes were no more detectable, after 5.5 months thickness of the gastric wall and finally after 6.6 month the previous abolished layering of the gastric wall returned to normal. CONCLUSION: In patients with gastric non-Hodgkin's lymphomas endoscopic ultrasound seems to be the only valid method which demonstrates early changes of the gastric wall and its layering in an appropriate way and might therefore in addition be capable to differentiate between CR, recurrent or refractory non-Hodgkin's lymphoma.


Subject(s)
Endosonography , Lymphoma, B-Cell, Marginal Zone/diagnostic imaging , Stomach Neoplasms/diagnostic imaging , Adult , Aged , Female , Follow-Up Studies , Humans , Lymphoma, B-Cell, Marginal Zone/therapy , Male , Middle Aged , Multicenter Studies as Topic , Neoplasm Recurrence, Local/diagnostic imaging , Prospective Studies , Stomach Neoplasms/therapy , Time Factors
5.
Dig Liver Dis ; 35(1): 24-31, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12725604

ABSTRACT

BACKGROUND: Patients with extensive, long-standing ulcerative colitis have increased risk of colorectal cancer. AIMS: To improve the detection of high-risk patients, using a combination of colonic cytology, histology, and DNA image cytometry after segmental colonic lavage. PATIENTS: A series of 16 patients (8 high-risk patients) with ulcerative colitis were investigated. METHODS: After segmental lavage step, biopsies were obtained. Gradient centrifugation of the colonic fluid was performed for isolation and purification of epithelial cells. The smears and biopsy specimens obtained were stained for routine interpretation and for DNA image cytometry. RESULTS: Segmental lavage could be performed in all patients. Specimens from two high-risk patients showed low grade dysplasia and atypia by means of histology and cytology, respectively. In one patient, without increased colorectal cancer risk, atypia was detected. Three patients in the high-risk group, two of those diagnosed as positive for dysplasia and atypia, showed aneuploidy histologically and cytologically. DNA aneuploidy, in cytological material, was found exclusively in three low-risk patients, one of those had atypia cytologically. CONCLUSIONS: Isolation and purification of epithelial cells after segmental colonic lavage using density gradient centrifugation can be performed as part of routine endoscopy. It provides information about atypical cells and DNA aneuploidy as additional markers of malignant transformation. The combination of cytologic examination and DNA image cytometry might improve the detection of high-risk ulcerative colitis patients.


Subject(s)
Colitis, Ulcerative/diagnosis , Colonic Neoplasms/diagnosis , Image Cytometry , Adult , Aged , Centrifugation, Density Gradient , Colonic Neoplasms/pathology , Colonoscopy , Female , Humans , Male , Middle Aged , Ploidies , Therapeutic Irrigation
6.
Endoscopy ; 34(10): 801-7, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12244502

ABSTRACT

BACKGROUND AND STUDY AIMS: Various methods of fluorescence excitation and detection have been developed in gastrointestinal endoscopy. This study reports an endoscopic technique using locally applied fluorescein-labeled antibodies for in-vivo detection of colorectal dysplasia and carcinoma. PATIENTS AND METHODS: Fluorescence endoscopy with a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen (CEA) was carried out in 27 patients with colonic polypoid lesions. During conventional colonoscopy, the monoclonal antibody was applied directly onto the mucosal surface. After an incubation time of 10 min, specific fluorescence was visualized with a conventional endoscope whose optical range was increased via two narrow-band filters. RESULTS: Fluorescence in vivo was present in 19 out of 25 carcinomas and in three of eight adenomas. The technique failed in the presence of mucosal ulceration or bleeding. One fluorescence-positive villous adenoma showed high-grade dysplasia, and another fluorescence-positive polypoid lesion was diagnosed as carcinoma in adenoma. Normal-appearing mucosa was fluorescence-negative in all cases. Endoscopic fluorescence significantly correlated with the CEA expression of luminal epithelial cells as determined immunohistochemically (Wilcoxon-Mann-Whitney U-test, P < 0.01). In all cases without ulceration or bleeding, the specificity of fluorescence endoscopy was 100%, the sensitivity was 78.6%, and the accuracy was 89.3%. CONCLUSIONS: Fluorescence endoscopy using fluorescein-labeled monoclonal antibody against CEA was shown to be positive in most cancers and some adenomas. Further and larger studies will be needed to demonstrate the value of this technique for differential diagnosis.


Subject(s)
Adenoma/diagnosis , Carcinoembryonic Antigen/analysis , Carcinoma/diagnosis , Colonoscopy/methods , Colorectal Neoplasms/diagnosis , Adenoma/immunology , Adult , Aged , Aged, 80 and over , Antibodies, Monoclonal/chemistry , Carcinoembryonic Antigen/immunology , Carcinoma/immunology , Colorectal Neoplasms/immunology , Female , Fluorescein/chemistry , Humans , Immunohistochemistry , Male , Middle Aged , Sensitivity and Specificity
7.
Dig Dis Sci ; 46(4): 870-8, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11330427

ABSTRACT

The increased risk of colorectal cancer in patients with extensive, long-standing ulcerative colitis is well established. The interpretation of dysplasia as the common precursor lesion of colorectal cancer in ulcerative colitis is, however, subject to inter- and intraobserver variation. The histologic diagnosis is particularly difficult in the presence of acute inflammation. Therefore, the analysis of ploidy patterns might be a more objective diagnostic tool. In the present study, the correlation of ploidy and dysplasia of the colonic mucosa was evaluated in the absence and presence of inflammation. Image cytometry was performed on 561 fixed, paraffin-embedded tissue specimens from 67 patients with ulcerative colitis. Twenty patients had long-standing and extensive disease, including eight patients in whom the colitis was associated with colorectal cancer. Dysplasia was only found in patients with long-standing colitis or with colorectal cancer and was significantly more often diagnosed in the case of concomitant inflammation. On the other hand, aneuploid patterns were shown to occur independent of inflammatory activity. Aneuploidy was present in all colorectal carcinomas associated with ulcerative colitis and in 46.2% of specimens with dysplasia. Moreover, aneuploidy was detectable in four of 12 samples with low-grade dysplasia as well as in one case devoid of any dysplastic alteration. Ulcerative colitis patients with low-grade dysplasia plus aneuploidy probably represent a subgroup that might be at higher risk of developing colorectal cancer than patients with low-grade dysplasia alone. All in all, image cytometry analysis might be instrumental in identifying neoplastic lesions even in cases of increased inflammatory activity or regenerative change.


Subject(s)
Colitis, Ulcerative/diagnosis , Colitis, Ulcerative/genetics , Adolescent , Adult , Aged , Child , DNA/analysis , Female , Flow Cytometry , Humans , Male , Middle Aged , Ploidies
8.
Dtsch Med Wochenschr ; 125(4): 75-80, 2000 Jan 28.
Article in German | MEDLINE | ID: mdl-10686956

ABSTRACT

BACKGROUND AND OBJECTIVE: Nowadays ultrasonic endoscopy is accepted as the most accurate method in the preoperative TNM staging of oesophageal tumour. At the time a diagnosis of oesophageal is made, 25-62% of patients have marked oesophageal stricture due to an advanced stage of the tumour. As a result, it is often impossible to pass a conventional endoscope and the examination is incomplete or a dilator has to be introduced at high risk of perforation or other complications. An ultrasonic oesophagoprobe (Olympus MH 908) with a diameter of 7.9 mm, its tip acting as a dilator has been developed so that even in high-grade oesophageal stricture a complete and low-risk investigation can be undertaken. The value of this instrument has been compared prospectively with that of a standard ultrasonic endoscope in patients with oesophageal stricture due to carcinoma and in relation to the postoperative histology. PATIENTS AND METHODS: Between May 1996 and February 1997, 62 patients (55 men, 7 women; average age 55.8 [41-82] years) with suspected or histologically confirmed oesophageal carcinoma were examined with the standard ultrasonic endoscope and the new oesophagoprobe. The two independent results were related to the postoperative histology. RESULTS: It was possible to compare the endoscopic results with the postoperative histology in 47 patients. In 55.8% it was not possible to pass the stricture with the standard ultrasonic endoscope (SE) so that an accuracy of only 41% was obtained in the T stage and 56.4% in the N stage. But with the oesophagoprobe (OP) an accuracy of 74.5% in the T stage and of 63% in the N stage were achieved. The difference in the findings between the two instruments was highly significant (p < 0.001) in those patients in whom the SE could not be passed through the stricture. For the T stage the accuracy was 14.3% vs. 76.2% (SE vs. OP); in the N stage it was 38.1% and 57.2%, respectively. When both instruments could be passed the results were comparable. CONCLUSIONS: Examination with the ultrasonic oesophagoprobe is a reliable and accurate method free of complications for the preoperative assessment of oesophageal carcinoma with stricture.


Subject(s)
Carcinoma/diagnostic imaging , Endosonography/instrumentation , Esophageal Neoplasms/diagnostic imaging , Esophageal Stenosis/diagnostic imaging , Esophagus/diagnostic imaging , Preoperative Care/instrumentation , Adult , Aged , Aged, 80 and over , Carcinoma/complications , Carcinoma/pathology , Endosonography/methods , Endosonography/statistics & numerical data , Esophageal Neoplasms/complications , Esophageal Neoplasms/pathology , Esophageal Stenosis/etiology , Esophageal Stenosis/pathology , Female , Humans , Male , Middle Aged , Neoplasm Staging , Preoperative Care/methods , Prospective Studies
9.
Z Gastroenterol ; 37(4): 277-81, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10378363

ABSTRACT

The causes of Budd-Chiari syndrome (BCS) comprise several diseases leading to thrombophilia. One of the most common thrombophilic disorders is resistance against activated protein C, caused by a single point mutation of the factor V gene. In December 1993, a 22-year-old patient was given a diagnosis of subacute BCS with occlusion of all major hepatic veins. Placement of a transjugular intrahepatic portosystemic stent shunt led to rapid disappearance of ascites and hepatic encephalopathy. During the following two years, recurrent partial occlusions of the shunt were treated by balloon angioplasty. The cause of the BCS still being unknown, in October 1996 we performed extensive laboratory investigations concerning states of thrombophilia and found moderately elevated IgG anticardiolipin antibodies (19.7 U/ml) and a resistance against activated protein C caused by heterozygosity for a point mutation of the factor V gene (1691G-->A; factor V Leiden). As a consequence, oral anticoagulation with coumarin was initiated. In October 1997, elective liver transplantation was performed which led to disappearance of APC resistance. Moreover, IgG anticardiolipin antibodies have been negative since then. If BCS is caused by APC resistance, liver transplantation not only treats the chronic liver disease but also cures the state of thrombophilia since factor V is mainly synthesized in the liver.


Subject(s)
Budd-Chiari Syndrome/therapy , Factor V/genetics , Liver Transplantation , Portasystemic Shunt, Transjugular Intrahepatic , Activated Protein C Resistance/genetics , Adult , Budd-Chiari Syndrome/blood , Budd-Chiari Syndrome/genetics , Combined Modality Therapy , Humans , Male , Point Mutation , Prognosis , Thrombophilia/genetics , Thrombophilia/therapy
10.
Dermatology ; 198(2): 130-2, 1999.
Article in English | MEDLINE | ID: mdl-10325458

ABSTRACT

BACKGROUND: Chronic urticaria is one of the most frequent skin diseases. Its cause, however, remains unsolved in a large number of cases. Recent investigations pointed to a potential role of Helicobacter pylori infection of the upper gastrointestinal tract as a possible causative agent in chronic urticaria. OBJECTIVE: The aim of this study was to examine the effect of a 14-day eradication therapy on chronic urticaria. METHODS: Thirty patients with chronic urticaria and confirmed H. pylori infection were treated with amoxicillin and omeprazole. Follow-up was conducted over a period of 6 months concerning eradication of H. pylori and remission of urticaria. RESULTS: Only 8 out of 30 patients (26.7%) showed clinical improvement or disappearance of their urticarial symptoms. CONCLUSION: Though our results do not support the preliminary data of previous studies, the role of H. pylori as a possible bacterial focus of chronic urticaria has to be further investigated.


Subject(s)
Helicobacter Infections/complications , Helicobacter pylori , Urticaria/etiology , Adult , Amoxicillin/administration & dosage , Anti-Ulcer Agents/administration & dosage , Chronic Disease , Drug Therapy, Combination , Female , Gastritis/complications , Gastritis/drug therapy , Gastritis/microbiology , Helicobacter Infections/drug therapy , Humans , Male , Middle Aged , Omeprazole/administration & dosage , Penicillins/administration & dosage , Peptic Ulcer/complications , Peptic Ulcer/drug therapy , Peptic Ulcer/microbiology , Prospective Studies
11.
Am J Gastroenterol ; 94(2): 404-9, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10022637

ABSTRACT

OBJECTIVES: Patients with extensive, long-standing ulcerative colitis (UC) have an increased risk for developing colorectal cancer. In this study, we wanted to establish a method for retrieving cytological material after segmental colonic lavage for further cytopathological investigations and for performing DNA image cytometry. METHODS: Ten patients with long-standing and extensive ulcerative colitis and 10 patients without macroscopic abnormalities were investigated. After segmental colonic lavage during routine colonoscopy a three-layer (1.146, 1.075, and 1.046 g/ml, respectively) density gradient centrifugation of the retrieved colonic fluid was performed for isolation and purification of the epithelial cells. For identification of the epithelial cells flow cytometry with monoclonal antibody against cytokeratin and counterstaining with propidium iodine was performed. The smears obtained were stained for routine cytopathological interpretation and for DNA image cytometry. RESULTS: In eight of 10 UC patients and in nine of 10 control group patients adequate cytological material could be obtained. The band on top of the density gradient at 1.046 g/ml could be identified as the epithelial cells. Atypical cells were found in smears of three UC patients. In these patients and in one additional patient aneuploid stemlines could be detected. In smears of control group patients neither atypical cells nor aneuploidy were present. CONCLUSIONS: Isolation and purification of epithelial cells after segmental colonic lavage by using density gradient centrifugation was performed. This cytological material is adequate for cytopathological interpretation and for DNA image cytometry. Information about atypical cells and DNA aneuploidy as an additional marker of malignant transformation in UC patients was obtained. The combination of cytological examination and DNA image cytometry might improve the detection of UC patients with high risk for colorectal cancer.


Subject(s)
Colitis, Ulcerative/pathology , Colon/pathology , Colorectal Neoplasms/pathology , Aneuploidy , Case-Control Studies , Centrifugation, Density Gradient , Colitis, Ulcerative/complications , Colonoscopy , Colorectal Neoplasms/epidemiology , Epithelial Cells/pathology , Humans , Image Cytometry , Risk Factors , Therapeutic Irrigation
12.
Gastrointest Endosc ; 47(2): 154-61, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9512281

ABSTRACT

BACKGROUND: Colorectal carcinoma is a common malignant disease with a high mortality rate. It arises most frequently in adenomas of the colorectum with different grades of dysplasia. Endoscopy and biopsy are among the most reliable diagnostic tools currently available. Diagnosis of malignancy at an early stage is sometimes difficult. This study reports on a new method, "immunoscopy", that combines endoscopy and immunofluorescent diagnostic procedures; it is the first reported use of locally applied fluorescein-labeled antibodies for detection of colorectal carcinomas. METHODS: A monoclonal antibody against carcinoembryonic antigen was fluorescein labeled. In phase I, formalin-fixed tissue samples, and in phase II, postoperative fresh tissue samples from tumorous and nontumorous areas of resected colorectal carcinomas were studied. After being incubated for 10 minutes, specific fluorescence was visualized with a conventional endoscope whose range was increased by means of two narrow band filters. RESULTS: Because of high levels of autofluorescence, evaluation of immunoscopic investigations using formalin fixed tissue (phase I) was not carried out. Immunoscopic investigation with postoperative fresh tissue samples could differentiate between tumorous and nontumorous areas (p < 0.001). Immunoscopic results were compared with data from immunohistochemical investigations with anti-carcinoembryonic antigen on the same tissue samples. CONCLUSIONS: Immunoscopy can differentiate between malignant and benign mucosal areas in fresh tissue samples. The high sensitivity of immunoscopy could potentially make it a useful diagnostic complement to routine endoscopy.


Subject(s)
Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/immunology , Endoscopy, Digestive System/instrumentation , Fluorescent Antibody Technique , Adenoma/diagnosis , Adenoma/immunology , Carcinoembryonic Antigen/analysis , Carcinoma/diagnosis , Carcinoma/immunology , Colorectal Neoplasms/pathology , Endoscopy, Digestive System/methods , Humans
13.
Z Gastroenterol ; 36(12): 1059-73, 1998 Dec.
Article in German | MEDLINE | ID: mdl-10025058

ABSTRACT

By the end of the eighties mesh stents were implanted in malignant stenoses of the biliary and pancreatic ducts for the first time. In the following years, self-expanding as well as balloon-expandable mesh stents were increasingly implanted in malignant stenoses by radiologists or interventional gastroenterologists, either percutaneously or endoscopically retrograde. In randomized comparative studies different teams showed relevant advantages of this new type of prosthesis in comparison to the commonly used plastic stents. Especially the significantly lower rate of late complications and longer patency rates speak in favor of the mesh stents. The higher cost of the mesh stent makes it important to carefully select patients before implantation, to let patients with potentially longer survival time profit from the advantages of the procedure. Expandable mesh stents were successfully implanted in benign stenoses of the biliopancreatic ducts as well, although the lack of randomized comparative studies makes a final assessment difficult. Concluding from already presented results, there might be a new therapeutical option for selected patients with benign stenoses of the biliopancreatic ducts.


Subject(s)
Bile Duct Neoplasms/therapy , Cholestasis, Extrahepatic/therapy , Metals , Stents , Cholestasis, Extrahepatic/etiology , Cost-Benefit Analysis , Humans , Palliative Care/economics , Prosthesis Design/economics , Randomized Controlled Trials as Topic , Stents/economics , Treatment Outcome
14.
Dtsch Med Wochenschr ; 122(3): 41-9; discussion 50, 1997 Jan 17.
Article in German | MEDLINE | ID: mdl-9072463

ABSTRACT

BASIC PROBLEM AND OBJECTIVE OF STUDY: The power of resolution of conventional imaging methods is too low for the diagnosis of very small pancreaticobiliary tumours. High-frequency ultrasound transducers (20 MHz), adapted to the dimensions of the pancreaticobiliary systems (2 mm diameter), make intraductal ultrasound examination possible during endoscopic retrograde cholangiopancreatography (ERCP). In a prospective study the invasiveness and diagnostic value of intraductal ultrasound (IDUS) was compared with ERCP, endosonography (ES) and computed tomography (CT). PATIENTS AND METHODS: During ERCP in 51 consecutive patients an intraductal ultrasound transducer was introduced into the pancreaticobiliary duct system, the results being compared with those obtained with the other imaging modalities and histopathological findings, if available. RESULTS: IDUS of the pancreatic and bile duct systems is a rapid, simple and reliable method during ERCP and provides valuable additional information on periductal tissues. In the diagnosis of carcinoma of the pancreas its sensitivity was 75% (six of eight cases), that of ERCP 37% (3/8), ES 50% (4/8) and CT 37% (3/8). In the diagnosis of biliary tract tumour the sensitivity of the different modalities (in the above order) was 89% (8/9), 78% (7/9), 33% (3/9) and 33% (1/3). Specificity was 67% (2/3), 67% (2/3), 67% (2/3) and 33% (3/9); predictability 89%, 88%, 75% and 60%. CONCLUSIONS: The use of small ultrasound catheter transistor system in the biliary and pancreatic ducts, introduced during ERCP, is technically simple and has few complications. It is a valuable addition to ERCP in the precise diagnosis of small pancreaticobiliary lesions.


Subject(s)
Bile Ducts, Extrahepatic/diagnostic imaging , Endosonography , Pancreatic Ducts/diagnostic imaging , Adult , Aged , Aged, 80 and over , Cholangiopancreatography, Endoscopic Retrograde , Cholestasis, Extrahepatic/diagnostic imaging , Constriction, Pathologic/diagnostic imaging , Endosonography/instrumentation , Female , Humans , Male , Middle Aged , Pancreatic Ducts/pathology , Pancreatic Neoplasms/diagnostic imaging , Pilot Projects , Sensitivity and Specificity , Tomography, X-Ray Computed
15.
Aliment Pharmacol Ther ; 11(6): 1047-52, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9663828

ABSTRACT

BACKGROUND: Budesonide, a corticosteroid with high topical anti-inflammatory activity and low systemic activity, has been shown to prolong time to relapse in Crohn's disease. In the present study, the efficacy of budesonide in an oral pH-modified-release formulation was evaluated for maintenance treatment in patients with steroid-dependent ulcerative colitis. METHODS: Fourteen patients with steroid-dependent ulcerative colitis in the reduction phase of conventional glucocorticosteroids (c-GCS) following a severe attack, were treated with budesonide 3 mg t.d.s. for 6 months. The primary investigation parameters were changes in the clinical activity index (CAI) and in the daily dose of c-GCS. RESULTS: In 11 cases the CAI improved significantly and treatment with c-GCS could be terminated. Three patients experienced relapse and needed further c-GCS treatment. The average daily dose of c-GCS and the average value of the CAI before treatment with budesonide were significantly higher in the relapse group than in the remission group. CONCLUSIONS: In patients with c-GCS-dependent ulcerative colitis, a dose of 9 mg budesonide daily in an oral pH-modified-release formulation was well tolerated, significantly decreased the CAI, and rendered c-GCS unnecessary in the majority of cases.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Budesonide/therapeutic use , Colitis, Ulcerative/drug therapy , Steroids/adverse effects , Administration, Oral , Administration, Topical , Adolescent , Adult , Aged , Anti-Inflammatory Agents/adverse effects , Budesonide/adverse effects , Chronic Disease , Female , Glucocorticoids , Humans , Hydrogen-Ion Concentration , Male , Middle Aged , Pilot Projects , Substance-Related Disorders
16.
Arch Intern Med ; 156(22): 2545-50, 1996.
Article in English | MEDLINE | ID: mdl-8951297

ABSTRACT

BACKGROUND: Studies on human immunodeficiency virus-infected children suggest that high-dose immune globulin therapy might be beneficial in reducing the episodes of recurrent infections. In adults, comparable studies are not available. OBJECTIVE: To determine the efficacy of intravenous (IV) immune globulin therapy in preventing infections and reducing days with fever, as well as the duration and frequency of hospitalization for human immunodeficiency virus-infected adults, in a prospective, randomized outpatient clinical trial. METHODS: Adult patients who met Centers for Disease Control and Prevention criteria B and C were randomized to be treated with (n = 70) or without (n = 57) IV immune globulin. Patients who were assigned to treatment with IV immune globulin received 400 and 200 mg/kg of this drug initially and every 21 days thereafter, respectively. Primary end points were the occurrence of laboratory-proved or clinically diagnosed infections and death caused by infection. RESULTS: In comparison with patients in the control group, IV immune globulin treatment significantly increased the time for which the patients who met Centers for Disease Control and Prevention criteria B and C were free from serious infection (P < .001). Twelve (17%) of the patients who received IV immune globulin had infection-related deaths compared with 20 (35%) of the control patients; however, this was not statistically significant (P = .06). Furthermore, immune globulin treatment was associated with an overall reduction in the number and duration of hospitalizations for short-term care (P = .002), days with fever (P < .001), and frequency of diarrhea (P < .001). Because of these results, the study was stopped by the local ethical board. CONCLUSION: Prophylactic IV immune globulin treatment in human immunodeficiency virus-infected adults decreases the frequency of serious infections and is associated with a reduction of hospitalization for short-term care.


Subject(s)
HIV Infections/complications , Immunoglobulins, Intravenous/therapeutic use , Infection Control/methods , Adult , Female , Hospitalization/statistics & numerical data , Humans , Infections/etiology , Male , Middle Aged , Prospective Studies , Treatment Outcome
17.
Am J Med ; 101(4): 357-63, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8873505

ABSTRACT

PURPOSE: Nicotine replacement therapy has become a popular therapy for smokers attempting to stop smoking. Unfortunately, some subjects continue to smoke while receiving it. Since nicotine is believed to be the primary constituent of cigarette smoke responsible for its acute adverse effects on myocardial oxygen supply and demand, concomitant nicotine replacement therapy and smoking theoretically could provoke a marked decrease in myocardial oxygen supply and increase in demand. This study was performed to assess the effects of cigarette smoking with and without concomitant intranasal nicotine spray on: (a) myocardial oxygen demand, (b) coronary arterial dimensions, and (c) the development of acute cardiovascular tolerance. PATIENTS AND METHODS: In 19 smokers referred for cardiac catheterization for the evaluation of chest pain, we assessed the effects of cigarette smoking with and without concomitant intranasal nicotine spray on: (a) heart rate-systolic arterial pressure product (an estimate of myocardial oxygen demand), (b) coronary arterial dimensions (measured with computer-assisted quantitative arteriography), and (c) the development of acute cardiovascular tolerance. RESULTS: Smoking a first cigarette increased rate pressure product (P < 0.001) and decreased coronary arterial dimensions (P < 0.0001). Subsequently, neither variable was altered by intranasal nicotine spray or a second cigarette. Despite a substantial increase in serum nicotine concentration with nicotine spray and smoking, acute cardiovascular tolerance appears to develop. CONCLUSIONS: Cigarette smoking causes an increase in myocardial oxygen demand and concomitant coronary arterial vasoconstriction. However, further increases in the serum nicotine concentration do not cause a greater increase in demand or decrease in coronary arterial dimensions. These data suggest that humans acutely develop tolerance to an increasing nicotine concentration, thereby helping to explain the apparent lack of a potential synergistic adverse effect associated with continued smoking during nicotine replacement therapy.


Subject(s)
Coronary Vessels/drug effects , Myocardium/metabolism , Nicotine/administration & dosage , Oxygen Consumption/drug effects , Smoking/adverse effects , Vasoconstriction/drug effects , Administration, Intranasal , Adult , Cardiac Catheterization , Cineangiography , Coronary Angiography , Coronary Vessels/physiology , Female , Heart Rate/drug effects , Humans , Male , Middle Aged , Nicotine/pharmacology , Nicotine/therapeutic use , Smoking Cessation
20.
Ultraschall Med ; 17(3): 143-8, 1996 Jun.
Article in German | MEDLINE | ID: mdl-8767652

ABSTRACT

Endoscopic ultrasound (EUS) allows for intraluminal sonographic imaging of the oesophagus, stomach, pancreatobiliary duct system, the papilla of Vater, as well as the colon and rectum. EUS has proved valuable for diagnosis and staging of tumours of the upper intestinal tract. EUS can also provide valuable additional information concerning lesions that cannot be immediately classified. As doing this involves, first, removal of the conventional endoscope and, second, insertion of the echo endoscope, EUS is not suitable for routine examinations. Therefore EUS has remained an independent endoscopic diagnostic modality. Moreover, due to their diameter conventional echoendoscopes cannot be inserted into the pancreatobiliary duct system. Fine calibre high frequency ultrasound probes promise a resolution of less than 2 mm in diameter. The following report is a summary of a one-day workshop which took place in Muenster, Germany on Oct. 28, 1995. Its goal was to define the current state of the art of miniaturised endoscopic ultrasound probes in the field of gastroenterology. During this workshop, possible clinical applications for diagnosis, therapy, as well as follow-up were described and discussed. The potential of miniaturised endoscopic ultrasound probes was explored in terms of possible future technical developments.


Subject(s)
Gastrointestinal Diseases/diagnostic imaging , Transducers , Ultrasonography/instrumentation , Endoscopy, Gastrointestinal , Germany , Humans , Miniaturization
SELECTION OF CITATIONS
SEARCH DETAIL
...